The {pharmaceutical sector is increasingly exploring innovative treatment strategies for weight management , and the introduction of semaglutide 10mg doses represents the change. Healthcare professionals are cautiously consider the likely benefits and risks associated with this stronger strength product, notably in contrast with existing lower-dose